title: The reshaping of healthcare. Part 2.
abstract: Powerful new tools produced by the biotechnology revolution--predictive genetics (and ultimately genetic therapy) and immunotherapy--will eventually make obsolete much of our current armada of crude "halfway" technologies, and enable us to prevent most illness altogether. These advances were discussed in the May/June issue of the Journal. This article addresses their likely impact on healthcare delivery.
authors.forename: J C
authors.initials: JC
authors.lastname: Goldsmith
mesh_terms: D001709:Biotechnology / Q000639:trends*; D003422:Critical Care / Q000639:trends; D003695:Delivery of Health Care / Q000639:trends*; D016527:Drug Costs / Q000639:trends; D005544:Forecasting; D005818:Genetic Engineering / Q000639:trends; D006760:Hospitalization / Q000639:trends; D013514:Surgical Procedures, Operative / Q000639:trends; D014481:United States